Age; years | 52 (20–72) |
Gender; Male:Female | 23:34 |
Weight; kg / Height; cm | 70 (44–112) / 168 (155–185) |
BMI; kg m−2 | 25 (16–41) |
ASA class I/II/III | 5/49/3 |
Comorbidities 1 | Â |
Cardiovascular | 14 |
Pulmonary | 5 |
Renal | 4 |
Endocrine | 3 |
Neurological | 4 |
Obesity (BMI >30) | 8 |
Medication | Â |
Single ß-blocking agent | 2 |
Single ACE-inhibitor/AT2-blocker | 3 |
Single diuretic | 0 |
Combination of at least two drugs | 6 |
Other drugs2 | 27 |
None | 23 |
Origin of primary cancer | Â |
Appendix | 33 |
Ovary | 1 |
Colorectal | 13 |
Mesothelioma | 5 |
Gastric | 1 |
Other origin3 | 4 |